Paper39891787
The effects of ursodeoxycholic acid on Parkinson's disease, a mechanistic review of the recent evidence.
Razavi SM and 10 others. Metab Brain Dis, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. The effects of ursodeoxycholic acid on Parkinson's disease, a mechanistic review of the recent evidence. Papers, record 39891787. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39891787
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effects of ursodeoxycholic acid on Parkinson's disease, a mechanistic review of the recent evidence.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ursodeoxycholic Acid | Major topic |
| Parkinson Disease | Major topic |
| Neuroprotective Agents | Major topic |
| Humans | |
| Animals |
Source PubMed
References84
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22773138 | Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease. | Mol Neurobiol | 2012 | https://conductscience.org/library/papers/22773138 | PubMed |
| 2 | 31671869 | Preclinical Evaluation of UDCA-Containing Oral Formulation in Mice for the Treatment of Wet Age-Related Macular Degeneration. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/31671869 | PubMed |
| 3 | 30704685 | Parkinson's Disease. | Med Clin North Am | 2019 | https://conductscience.org/library/papers/30704685 | PubMed |
| 4 | 15377875 | MPTP as a mitochondrial neurotoxic model of Parkinson's disease. | J Bioenerg Biomembr | 2004 | https://conductscience.org/library/papers/15377875 | PubMed |
| 5 | 34620070 | Tremor and Rigidity in Patients with Parkinson's Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors. | CNS Neurol Disord Drug Targets | 2022 | https://conductscience.org/library/papers/34620070 | PubMed |
| 6 | 32205405 | Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids. | Infect Immun | 2020 | https://conductscience.org/library/papers/32205405 | PubMed |
| 7 | 30890425 | Parkinson's Disease and Parkinsonism. | Am J Med | 2019 | https://conductscience.org/library/papers/30890425 | PubMed |
| 8 | 37921943 | Updates in Parkinson's Disease Integrative Therapies: an Evidence-Based Review. | Curr Neurol Neurosci Rep | 2023 | https://conductscience.org/library/papers/37921943 | PubMed |
| 9 | 37651798 | Targeted protein degradation for the treatment of Parkinson's disease: Advances and future perspective. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37651798 | PubMed |
| 10 | 31757001 | Tauroursodeoxycholate-Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives. | Cells | 2019 | https://conductscience.org/library/papers/31757001 | PubMed |
| 11 | 29651747 | Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease. | Mol Neurobiol | 2018 | https://conductscience.org/library/papers/29651747 | PubMed |
| 12 | 38539252 | Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/38539252 | PubMed |
| 13 | 7824870 | Pharmacology of ursodeoxycholic acid, an enterohepatic drug. | Scand J Gastroenterol Suppl | 1994 | https://conductscience.org/library/papers/7824870 | PubMed |
| 14 | 27699602 | Tauroursodeoxycholic Acid Protects Against Mitochondrial Dysfunction and Cell Death via Mitophagy in Human Neuroblastoma Cells. | Mol Neurobiol | 2017 | https://conductscience.org/library/papers/27699602 | PubMed |
| 15 | 38193999 | Economic Burden of Parkinson's Disease: A Multinational, Real-World, Cost-of-Illness Study. | Drugs Real World Outcomes | 2024 | https://conductscience.org/library/papers/38193999 | PubMed |
| 16 | 24000005 | Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease. | Brain | 2013 | https://conductscience.org/library/papers/24000005 | PubMed |
| 17 | 33345721 | Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson's disease. | Nutr Neurosci | 2022 | https://conductscience.org/library/papers/33345721 | PubMed |
| 18 | 30882914 | Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population. | J Clin Pharmacol | 2019 | https://conductscience.org/library/papers/30882914 | PubMed |
| 19 | 33178028 | Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33178028 | PubMed |
| 20 | 31700226 | Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. | Mol Vis | 2019 | https://conductscience.org/library/papers/31700226 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943209 | Comparative Network Pharmacology and Molecular Docking Analysis of Ursodeoxycholic Acid and Tauroursodeoxycholic Acid in Alzheimer's Disease-Associated Molecular Networks. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943209 | PubMed |
| 42782818 | Blood-Mediated Gut-Brain Axis in Parkinson's Disease: Focus on α-Synuclein Transport and Microbiota Dysbiosis-Induced Inflammation. | Cells | 2026 | https://conductscience.org/library/papers/42782818 | PubMed |
| 42598050 | Gut-brain axis dysregulation in Parkinson's disease: Mechanisms linking microbiota to neuroinflammation and α-synuclein pathology. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42598050 | PubMed |
| 42263415 | Ursodeoxycholic acid mitigates cerebral ischemia/reperfusion injury by inhibiting thrombin-induced lipid peroxidation through activation of ALDH3A1. | Redox Biol | 2026 | https://conductscience.org/library/papers/42263415 | PubMed |
| 42154337 | The Influence of Gut Microbiome on Alpha-Synuclein Aggregation: Implications for Parkinson's Disease Pathogenesis. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42154337 | PubMed |
| 41727485 | Pleiotropic immunoregulation by bile acids in pathophysiology. | Front Immunol | 2026 | https://conductscience.org/library/papers/41727485 | PubMed |
| 41480102 | Bile acid-microbiota interactions in cardiometabolic diseases: mechanisms and emerging therapeutic approaches. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41480102 | PubMed |
| 41467439 | Microbiota-gut-brain axis and bile acids-driven neuromodulation. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/41467439 | PubMed |
| 41465592 | Gut-Brain Axis and Bile Acid Signaling: Linking Microbial Metabolism to Brain Function and Metabolic Regulation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465592 | PubMed |
| 41373461 | Emerging Roles of Bile Acids in Neuroinflammation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373461 | PubMed |
| 41021023 | Reduced cerebrospinal fluid taurine is associated with nigrostriatal dopaminergic deficits in drug-naïve Parkinson's disease. | J Neural Transm (Vienna) | 2026 | https://conductscience.org/library/papers/41021023 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39891787
GET https://conductscience.org/api/papers/v1/39891787/references?page=2